UIM9:XETRA:XETRA-UBS ETF SICAV - MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 43.405

Change

+0.32 (+0.74)%

Market Cap

N/A

Volume

4.64K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.56 (+1.23%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.76 (+0.77%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.32 (+1.34%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.16 (+1.19%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.09 (+1.59%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.26 (+1.10%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.12 (+0.93%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.52 (-0.90%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.08 (+0.79%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.20 (+0.16%)

USD 12.26B

ETFs Containing UIM9:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.21% 65% D 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.21% 68% D+ 62% D
Trailing 12 Months  
Capital Gain 11.41% 86% B+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.41% 86% B+ 81% B-
Trailing 5 Years  
Capital Gain 71.02% 68% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 71.02% 69% C- 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 10.66% 70% C- 70% C-
Dividend Return 11.59% 74% C 72% C
Total Return 0.93% 74% C 49% F
Risk Return Profile  
Volatility (Standard Deviation) 14.01% 38% F 49% F
Risk Adjusted Return 82.76% 73% C 76% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.